141 related articles for article (PubMed ID: 8686247)
1. [Evaluation of immunotherapy in breast cancer (stage III-IV) and in cancer of the corpus uteri (stage I-III)].
Mkrtchian LN; Movsesian MA; Adamian RT; Barsegian AM
Vopr Onkol; 1996; 42(1):66-9. PubMed ID: 8686247
[TBL] [Abstract][Full Text] [Related]
2. [Adjuvant immunotherapy for patients with cancer of corpus uteri].
Adamian RT; Movsesian MA
Vopr Onkol; 1997; 43(6):602-5. PubMed ID: 9479360
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
4. [Long-term effect on preoperative ulnaris arterial intubation chemotherapy in treatment of stage III breast cancer].
Huang C; Zhang X; Lu H; Wu X; Guan G; Wang C; Zhou Y; Zhang J
Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):412-4. PubMed ID: 11832070
[TBL] [Abstract][Full Text] [Related]
5. A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients.
Isaacs C; Slack R; Gehan E; Ballen K; Boccia R; Areman E; Kramer R; Hayes DF; Herscowitz H; Lippman M
Breast Cancer Res Treat; 2005 Sep; 93(2):125-34. PubMed ID: 16187232
[TBL] [Abstract][Full Text] [Related]
6. [Inflammatory breast cancer: 38 cases clinical report].
Huang J; Zhang P; Liu P; Ou GF; Wang ZP; Xu BH
Ai Zheng; 2002 Aug; 21(8):888-91. PubMed ID: 12478900
[TBL] [Abstract][Full Text] [Related]
7. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
[TBL] [Abstract][Full Text] [Related]
8. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
9. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of clinical effect, pathological response of tumor cells and the end results of combined treatment of locally advanced breast cancer].
Kharchenko VP; Voznyĭ EK; Galil-Ogly GA; Gurov SN; Dobrovol'skaia NI; Alinchenko LA; Bol'shakova SA
Vopr Onkol; 2000; 46(6):740-4. PubMed ID: 11219951
[TBL] [Abstract][Full Text] [Related]
11. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
12. [Effect of live tularemia vaccine on the counter-suppression of lymphocytes and the end results of the combined treatment of endometrial cancer].
Adamian RT; Markosian KM
Vopr Onkol; 2001; 47(1):52-4. PubMed ID: 11317536
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of stage IV breast carcinoma].
Vadalà G; Buffone A; Mangiameli A; Caragliano P; Figura C; Scalia A; Vadalà F
Minerva Chir; 1996 Oct; 51(10):799-803. PubMed ID: 9082208
[TBL] [Abstract][Full Text] [Related]
14. [The effect of tularemia live vaccine on contrasuppression of lymphocytes in patients with cancer of the corpus uteri during combined therapy and long term].
Movsesian MA; Adamian RT; Markosian KM
Vopr Onkol; 1999; 45(5):528-32. PubMed ID: 10629711
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant combined radiochemotherapy: a feasibility study of a new strategy in stages I and II].
Serin D; Aimard L; Kirscher S; Brewer Y; Félix-Faure C; Vincent P; Chauvet B; Reboul F
Bull Cancer; 1997 Mar; 84(3):247-53. PubMed ID: 9207869
[TBL] [Abstract][Full Text] [Related]
16. The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base.
Straughn JM; Numnum TM; Kilgore LC; Partridge EE; Phillips JL; Markman M; Thomas GM; Burke TW;
Gynecol Oncol; 2005 Dec; 99(3):530-5. PubMed ID: 16198401
[TBL] [Abstract][Full Text] [Related]
17. Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: treatment intervals and clinical outcomes.
Wright JL; Cordeiro PG; Ben-Porat L; Van Zee KJ; Hudis C; Beal K; McCormick B
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):43-50. PubMed ID: 17855006
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the treatment tactics in patients with stage II malignant neoplasms].
Vagner RI; Bokhman IaV; Gershanovich ML; Kanaev SV; Mel'nikov RA
Vopr Onkol; 1984; 30(4):66-71. PubMed ID: 6730408
[TBL] [Abstract][Full Text] [Related]
19. [New methods in the treatment of breast cancer].
Semiglazov VF
Vopr Onkol; 1997; 43(1):22-6. PubMed ID: 9133082
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
